[[{“value”:”
The ability to take a drug to market is an important milestone, but it is not the entire picture. To truly move the needle, both clinically and commercially, biopharma companies must fine-tune their teams, approaches and incentives to produce unique and innovative products.
The post Balancing Risk and Opportunity to Choose Winning Therapies appeared first on MedCity News.
“}]]
